HC Wainwright Issues Optimistic Outlook for SGMO Earnings

Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) – Stock analysts at HC Wainwright lifted their Q1 2025 earnings estimates for shares of Sangamo Therapeutics in a research note issued to investors on Monday, April 7th. HC Wainwright analyst P. Trucchio now anticipates that the biopharmaceutical company will post earnings of ($0.04) per share for the […]

Leave a Reply

Your email address will not be published.

Previous post Q1 EPS Estimates for Plug Power Reduced by Seaport Res Ptn
Next post Q1 EPS Estimate for Barfresh Food Group Reduced by Analyst